WANBURY
|
The Current P/B Ratio of WANBURY is 40.88.
Share Price | ₹263.0 | Jan 08,2025 |
Market Cap | ₹862.6 Cr | |
Book Value | ₹21.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 40.88x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹862.6 Cr] as on Jan 08,2025
(/) Book Value [ ₹21.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 40.88x ]
Thus, for WANBURY , the investors are currently willing to pay '40.88 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2024 at 22.63x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
WANBURY | 21.10 | 40.88 | 862.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.92 | 440,830.0 |
CIPLA LTD | 26,619.90 | 4.54 | 120,742.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.07 | 114,366.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.98 | 98,766.9 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.47 | 155,644.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.71 | 118,687.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.41 | 112,542.0 |
LUPIN LTD | 14,175.80 | 7.25 | 102,762.0 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.49 | 74,438.4 |
ABBOTT INDIA LTD | 3,658.73 | 17.18 | 62,845.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.49x |
Max industry PB | 40.88x |
Median industry PB | 7.25x |
Average industry PB | 11.72x |
You may also like the below Video Courses